申请人:Barsanti Paul A.
公开号:US20110028492A1
公开(公告)日:2011-02-03
The present invention provides a compound of formula (I):
and pharmaceutically acceptable salts, enantiomers, stereoisomers, rotamers, tautomers, diastereomers, or racemates thereof. Also provided is a method of treating a disease or condition mediated by CDK9.
本发明提供了一种化合物,其化学式为(I):
以及其药学上可接受的盐、对映体、立体异构体、转型异构体、互变异构体、顺反异构体或混合物。还提供了一种治疗由CDK9介导的疾病或症状的方法。